Skip to Main Content

Paper Details

Detection fidelity of AR mutations in plasma derived cell-free DNA.
Oncotarget
19
2017
AR, AR (tTC>, AR (tTC>cTC) F877L hotspot, AR mutations, F877L, androgen, androgen receptor, cell-free DNA, cfDNA, mCRPC, metastatic castration resistant prostate cancer, patients, plasma, plasma derived cell-free DNA, plasma-, plasma-derived cfDNA
Author NameAffiliation
Aparna PallavajjalaJohns Hopkins School of Medicine
Michael A CarducciJohns Hopkins School of Medicine
Michael A CarducciThe Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Channing J PallerJohns Hopkins School of Medicine
Channing J PallerThe Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Bruce J TrockThe James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Mario A EisenbergerThe James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Mario A EisenbergerJohns Hopkins School of Medicine
Mario A EisenbergerThe Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Emmanuel S AntonarakisThe James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Emmanuel S AntonarakisJohns Hopkins School of Medicine
Emmanuel S AntonarakisThe Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Ben Ho ParkJohns Hopkins School of Medicine
Ben Ho ParkThe Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Ben Ho ParkJohns Hopkins University
Ben Ho ParkJohns Hopkins School of Medicine
Ben Ho ParkThe Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Ben Ho ParkJohns Hopkins University
  • 1 - 18

Datasets